Advertisement
Advertisement
HALO
Halozyme Therapeutics, Inc.
107.20
USDSponsored
+0.20
+0.19%
Sep 11, 15:59 UTC -4
Closed
After-Market
106.32
-0.88
-0.82%
Halozyme Therapeutics, Inc. Financial Snapshot
| Market Cap | 12.07B |
| Beta | 0.88 |
| Earnings Per Share (EPS) | 3.35 |
| Price-to-Book (P/B) Ratio | 88.58 |
| Operating Margin | 35.92% |
| Total Debt/Equity (D/E) | 1495.48% |
| P/E Ratio | 21.74 |
| Return on Equity (ROE) | 260.98% |
| Current Ratio | 2.71% |
| Free Cash Flow | 413.06M |
